Human T lymphotropic virus type II (HTLV-II): Epidemiology, molecular properties, and clinical features of infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Hall, William W ^a,f   Ishak, Ricardo ^c   Zhu, Shi Wei ^a   Novoa, Patricia ^b   Eiraku, Nobutaka ^a   Takahashi, Hidehiro ^e   Da Costa Ferreira, Marizete ^b   Azevedo, Vania ^c   Ishak, Marluisa O G ^c   Da Costa Ferreira, Orlando ^b   Monken, Claude ^d   Kurata, Takeshi ^e  

^a ROCKEFELLER UNIVERSITY   (United States)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Clinical features; Epidemiology; Human T lymphotropic virus, type II (HTLV II); Molecular subtypes; Pathogenic properties

Indexed keywords

AMERICAN INDIAN; CLINICAL FEATURE; CONFERENCE PAPER; DRUG ABUSE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION RISK; POPULATION RISK; PRIORITY JOURNAL; VIRUS STRAIN;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 10144264557     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199600001-00031     Document Type: Conference Paper

References (93)

1. Hollsberg P, Hafler DA. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 1993;328:1173-82.
2. Hall WW. Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma. J Exp Med 1994;180: 1581-5.
3. Hall WW, Kubo T, Ijichi S, Takahashi T, Zhu SW. Human T-cell leukemia/lymphoma virus, type II (HTLV-II): emergence of an important newly recognised pathogen. Semin Virol 1994;5:165-78.
4. Hjelle B, Scalf R, Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood 1990;76:450-4.
5. Hjelle B, Mills R, Swenson S, Mertz G, Key C, Allen S. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J Infect Dis 1990;163:435-40.
6. Hjelle B. Human T-cell leukemia/lymphoma viruses: life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med 1991;115:440-50.
7. Levine PH, Jacobson S, Elliot R, et al. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-8.
8. Lairmore MD, Jacobson S, Gracia F, et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990;87:8840-4.
9. Duenas-Barajas E, Bernai JE, Vaught DR, et al. Coexistence of human T-lymphotropic virus types I and II among the Wuyuu Indians from the Guajira region of Columbia. AIDS Res Hum Retroviruses 1992;8:1851-5.
10. Fujiyama C, Fujiyoshi T, Miura Y, et al. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Columbia. J infect Dis 1993;168:1075-7.
11. Duenas-Barajas E, Bernai JE, Vaught DR, et al. Human retroviruses in Amerindians of Columbia: High prevalence of human T-cell lymphotropic virus type II infection among the Tunebo Indians. Am J Trop Med Hyg 1993;49:657-66.
12. Biglone M, Gessain A, Quiruelas S, et al. Endemic HTLV-II infection among Tobas and Matacos Amerindians from North Argentina. J AIDS 1993;6:631-3.
13. Ferrer JF, Pino del N, Esteban E, et al. High rate of infection with the human T-leukemia retrovirus type II in four Indian populations of Argentina. Virology 1993;197:576-84.
14. Maloney EM, Biggar RJ, Neel JV, et al. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-7.
15. Black FL, Biggar RJ, Neel JV, Maloney EM, Waters DJ. Endemic transmission of HTLV type II among Kayapo Indians. AIDS Res Hum Retroviruses 1994;10:1165-71.
16. Ishak R, Harrington W, Acevedo V, et al. Identification of human T-cell lymphotropic virus type IIa (HTLV-IIa) infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-21.
17. Cartier L, Araya F, Castillo JF, et al. Southernmost carriers of HTLV-I/II in the world. Jap J Can Res 1993;84:1-3.
18. Hall WW, Takahashi H, Liu C, et al. Multiple isolates and characteristics of human T-cell leukemia virus type II. J Virol 1992;66:2456-63.
19. Takahashi H, Zhu SW, Ijichi S, Vahlne A, Suzuki H, Hall WW. Nucleotide sequence analysis of human T-cell leukemia virus type II (HTLV-II) isolates. AIDS Res Hum Retroviruses 1993;9:715-9.
20. Hjelle B, Zhu SW, Takahashi H, Ijichi S, Hall WW. Endemic human T-cell leukemia virus type II infection in Southwestern US Indians involving two prototype variants of virus. J Infect Dis 1993;168:737-40.
21. Dube DK, Sherman MP, Saksena NK, et al. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-84.
22. Eiraku N, Novoa P, da Costa Ferreira M, et al. Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type II. J Virol 1996;70:148-92.
23. Igarishi T, Yamashita M, Miuta T, et al. Isolation and genomic analysis of human T lymphotropic virus type II from Ghana. AIDS Res Hum Retroviruses 1993;9:1039-42.
24. Eiraku N, Monken C, Kubo T, et al. Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retroviruses 1995;11:625-36.
25. Pardi D, Switzer WM, Hadlock KG, Kaplan JE, Lal RB, Folks TM. Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-IIb subtype from a Guaymi Indian. J Virol 1993;67:4659-64.
26. Ijichi S, Tajima K, Zaninovic V, et al. Identification of human T cell leukemia virus type IIb in the Wayu, an aboriginal population of Columbia. Jap J Can Res (Gann) 1993;84: 1215-8.
27. Switzer WM, Owen SM, Pieriazek D, et al. Molecular analysis of human T cell lymphotropic virus type II from Wayu Indians of Columbia demonstrates two subtypes of HTLV-IIb. Virus Genes 1995;10:153-62.
28. Kinoshita T, Tsujimoto A, Shimotohno K. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I associated myelopathy and adult T-cell leukemia. Int J Cancer 1991;47: 491-5.
29. Ratner L, Philpott T, Trowbridge DB. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type I of diverse geographical origins. AIDS Res Hum Retroviruses 1991;7:923-41.
30. Komurian F, Pelloquin F, Sonoda S, Osame N, de Thé G. Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res Hum Retroviruses 1992;8:429-34.
31. Switzer WM, Pieniazek D, Swanson P, et al. Phylogenetic relationship and geographic distribution of multiple human T cell lymphotropic viruses type II subtypes. J Virol 1995;69: 621-32.
32. Delaporte E, Louwagie J, Peeters M, et al. Evidence for HTLV-II infection in Central Africa. AIDS 1991;5:771-2.
33. Delaporte E, Monplaisir N, Louwagie J, et al. Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results. Int J Cancer 1992; 49:373-6.
34. Goubau P, Desmyter J, Ghesquire J, Kasereka B. HTLV-II infection among the pygmies. Nature (London) 1992;359: 201.
35. Goubau P, Desmyter J, Swanson P, et al. Detection of HTLV-II infection in Africans with type-specific serology. J Med Virol 1993;39:28-32.
36. Goubau P, Liu HF, deLarge GG, Vandamme A-M, Desmyter J. HTLV-II Seroprevalence in pygmies across Africa since 1970. AIDS Res Hum Retroviruses 1993;9:709-13.
37. Froment A, Delaporte E, Dazza MC, Larouze B. HTLV-II among pygmies from Cameroon. AIDS Res Hum Retroviruses 1993;9:707.
38. Gessain A, Fretz C, Koulibaly M, et al. Evidence of HTLV-II infection in Guinea, West Africa. J AIDS 1993;6:324-5.
39. Mauclere P, Gessain A, Garcia-Calleja JM, et al. HTLV-II in African prostitutes from Cameroon. AIDS 1993;7:1394-5.
40. Gessain A, Tuppin P, Kazanji M, et al. A distinct molecular variant of HTLV-IIB in Gabon, Central Africa. AIDS Res Hum Retroviruses 1994;10:753-5.
41. Gessain A, Mauclere P, Froment A, et al. Isolation and molecular characterization of a human T cell lymphotropic virus type II (HTLV-II) subtype B from a healthy pygemy living in a remote area of Cameroon. An ancient origin for HTLV-II in America. Proc Natl Acad Sci USA 1995;92: 4041-5.
42. Mauclere P, Maahieux R, Garcia-Calieja JM, et al. A new HTLV-II subtype A isolate in a HIV-I infected prostitute from Cameroon. AIDS Res Hum Retroviruses 1995;11:989-93.
43. Hall WW, Zhu SW, Horal P, Furuta Y, Zagaany G, Vahlne A. HTLV-II infection in Mongolia. Abstract 2. AIDS Res Hum Retroviruses 1994;10:443.
44. Feigal E, Murphy E, Vranizan K, et al. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 1991;164:36-42.
45. Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, II and III in intravenous drug abusers from an AIDS endemic region. JAMA 1986;255:3133-7.
46. Lee HH, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen ISY. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-5.
47. Tedder RS, Shanson DC, Jeffries DJ, et al. Low prevalence in the UK of HTLV-I and HTLV-II infection in subjects with AIDS, with extended lymphadenopathy, and at risk of AIDS. Lancet 1984;2:125-8.
48. Khabbaz RF, Onorato IM, Cannon RD, et al. Seroprevalence of HTLV-I and HTLV-II among intravenous drug abusers and persons in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-80.
49. Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990;336:575-6.
50. Fukushima Y, Takahashi H, Nakasono T, et al. Extraordinary high seropositivity rates of human T-cell lymphotropic virus type II (HTLV-II) in intravenous drug abusers in South Vietnam. AIDS Res Hum Retroviruses 1995;11:637-44.
51. Lee H, Idler KB, Swanson P, et al. Complete nucleotide sequence of HTLV-II isolate NRA: comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian drug users. Virology 1993;196:57-69.
52. Soriano V, Vallejo A, Ferrante P, et al. Circulating HTLV-II genotypes in southern Europe. J AIDS Hum Retroviruses 1995;10:255.
53. Anderson S, Ahmed R, Bredberg-Raden U, et al. HTLV-II infected Swedish intravenous drug abusers carry subtype A. J AIDS Hum Retroviruses 1995;10:280.
54. Biggar RJ, Buskell-Bales Z, Yakshe PN, Caussy D, Gridley G, Seeff L. Antibody to human retroviruses among drug users in three East Coast American cities, 1972-1976. J Infect Dis 1991;163:57-63.
55. Khabbaz RF, Hartel D, Lairmore M, et al. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection? J Infect Dis 1991;163:252-6.
56. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984;46:245-53.
57. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986;154:851-7.
58. Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S. Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol 1986; 20:253-60.
59. Nakano S, Ando Y, Saito K, et al. Primary infection of Japanese infants with adult T-cell leukemia-associated retrovirus (ATLV): evidence for viral transmission from mothers to children. J Infect 1986;12:205-12.
60. Donegan E, Busch MP, Galleshaw JA. Transfusion of blood components from a donor with human lymphotropic virus type II (HTLV-II) infection. Ann Intern Med 1990;113: 555-6.
61. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. The American Red Cross HTLV-I/II Collaborative Study Group. Transmission of human T-lymphotropic virus type I and II by blood transfusion: a retrospective study of recipients of blood components (1983 through 1988). Arch Intern Med 1991;151:2043-8.
62. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C. Transmission of human T cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994;170:206-10.
63. Hjelle B, Cyrus S. Evidence for sexual transmission of human T lymphotropic virus type II. Ann Intern Med 1992;116: 90-1.
64. Vitels CR, Gracia FI, Giusti RA, et al. Evidence for sexual and mother to child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama. J Infect Dis 1995;171:1022-6.
65. Hino S, Yamaguchi K, Katamine S, et al. Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res (Gann) 1985;76:474-80.
66. Kusuhara K, Sonoda S, Takahasi K, Tokugawa K, Fukushige J, Veda K. Mother-to-child transmission of human T-cell leukemia virus type-I (HTLV-I): a fifteen-year follow-up study in Okinawa, Japan. Int J Cancer 1987;40:755-7.
67. Heniene W, Woods T, Green D, et al. Detection of HTLV-II in breast milk of HTLV-II infected mothers. Lancet 1992; 340:1157-8.
68. Lal RB, Gongora-Biachi RA, Pardi D, Switzer WM, Goldman I, Lal AA. Evidence for mother to child transmission of human T lymphotropic virus type II. J Infect Dis 1993;168: 586-91.
69. Kaplan JE, Abrams S, Shaffer N. Low risk of mother to child transmission of human T-lymphotropic virus, type II (HTLV-II) in non-breast fed infants. J Infect Dis 1992;166: 892-5.
70. Pardi D, Kaplan JE, Coligan JE, Folks TM, Lal RB. Identification and characterisation of an extended tax protein in human T-cell lymphotropic virus type II subtype b isolates. J Virol 1993;67:7663-7.
71. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
72. Rosenblatt JD, Golde DW, Wachsman W, et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986;315:372-7.
73. Rosenblatt JD, Giorgi JV, Golde DW, et al. Integrated human T-cell leukemia virus II genome in CD8+ T cells from a patient with "atypical" hairy cell leukemia: evidence for distinct T and B cell lymphoproliferative disorders. Blood 1988;71:363-9.
74. Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med 1991;91:300-9.
75. Bryz-Gornia V, Bushunow P, Amin R, Hutchinson B, Dube D, Poiesz B. Cutaneous T-cell lymphoma in a patient with HTLV-II and HIV-I. AIDS Res Hum Retroviruses 1994;10: 474 (abstr D104).
76. Ijichi S, Ramundo MB, Takahashi H, Hall WW. In vivo cellular tropism of human T cell leukemia virus type II (HTLV-II). J Exp Med 1992;176:293-6.
77. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropisms of human T cell leukemia virus type I. J Virol 1990;64:5682-7.
78. Lal RB, Owen SM, Rudolph DL, Dawson C, Prince H. In vivo cellular tropism of human T lymphotropic virus type II is not restricted to CD8+ cells. Virology 1995;210:441-7.
79. Martin MP, Biggar RJ, Hamlin-Greer G, Staal S, Mann D. Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res Hum Retroviruses 1993;9:715-9.
80. Loughran TP, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus type II in a patient with large granular lymphocyte leukemia. Blood 1992;80: 1116-9.
81. Heneine W, Chan WC, Lust JA, et al. HTLV-II infection is rare in patients with large granular lymphocyte leukemia. J AIDS 1994;7:736-7.
82. Zucker-Franklin D, Hooper WC, Evatt BL. Human lymphotropic retroviruses associated with mycosis fungoides and evidence that human T-cell lymphotropic virus type II (HTLV-II) as well as HTLV-I may play role in the disease. Blood 1992;80:1537-45.
83. Lal RB, Rudolph DL. Constitutive production of interleukin 6 and tumor necrosis factor-a from spontaneously proliferating T-cells in patients with human T-cell lymphotropic virus type I/II. Blood 1991;78:571-4.
84. Lal RB, Rudolph D, Buckner C, Pardi D, Hooper WG. Infection with human lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and interleukin 6. Blood 1993;81:1827-32.
85. Lefrere HH, Courouse AM, Mariotti M. Rapid progression to AIDS in dual HIV-I/HTLV-I infection. Lancet 1990;336: 509.
86. Visconti A, Visconti L, Bellocco R, et al. HTLV-II/ HIV-I coinfection and risk for progression to AIDS among intravenous drug users. J AIDS 1993;6:1228-37.
87. Berger JR, Svenningsson A, Raffanti S, Resnick L. Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-I and HTLV-II. Neurology 1991;41:85-7.
88. Rosenblatt JD, Tomkins P, Rosenthal M, et al. Progressive spastic myelopathy in a patient co-infected with HIV-I and HTLV-II: antibodies to the human homologue of rig in blood and cerebrospinal fluid. Presented at V International Conference on Human Retrovirology; HTLV, Kumamoto, Japan, 1992:abstr O-24.
89. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
90. Harrington WJ, Sheremata W, Hjelle B, et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-4.
91. Sheremata WA, Harrington WJ Jr, Bradshaw PA, et al. Association of "(tropical) ataxic neuropathy" with HTLV-II. Virus Res 1993;29:71-7.
92. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Subayl DJ. Isolation of HTLV-II from a patient with chronic progressive neurological disease indistinguishable from HTLV-I associated myelopathy/tropical spastic paraparesis. Ann Neurol 1993;33:392-5.
93. Murphy EL, Engstrom JW, Miller K, Sacher RA, Busch MP, Hollingsworth CG. HTLV-II associated myelopathy in a 43 year old woman. Lancet 1993;371:757-8.